153 related articles for article (PubMed ID: 1989686)
1. Characterization of the kinetic pathway for fibrin promotion of alpha-thrombin-catalyzed activation of plasma factor XIII.
Naski MC; Lorand L; Shafer JA
Biochemistry; 1991 Jan; 30(4):934-41. PubMed ID: 1989686
[TBL] [Abstract][Full Text] [Related]
2. Catalytic competence of human alpha- and gamma-thrombin in the activation of fibrinogen and factor XIII.
Lewis SD; Lorand L; Fenton JW; Shafer JA
Biochemistry; 1987 Dec; 26(24):7597-603. PubMed ID: 3427095
[TBL] [Abstract][Full Text] [Related]
3. Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin.
Higgins DL; Lewis SD; Shafer JA
J Biol Chem; 1983 Aug; 258(15):9276-82. PubMed ID: 6409903
[TBL] [Abstract][Full Text] [Related]
4. Alpha-thrombin-catalyzed hydrolysis of fibrin I. Alternative binding modes and the accessibility of the active site in fibrin I-bound alpha-thrombin.
Naski MC; Shafer JA
J Biol Chem; 1990 Jan; 265(3):1401-7. PubMed ID: 2295636
[TBL] [Abstract][Full Text] [Related]
5. Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen.
Janus TJ; Lewis SD; Lorand L; Shafer JA
Biochemistry; 1983 Dec; 22(26):6269-72. PubMed ID: 6661434
[TBL] [Abstract][Full Text] [Related]
6. Regulation of formation of factor XIIIa by its fibrin substrates.
Lewis SD; Janus TJ; Lorand L; Shafer JA
Biochemistry; 1985 Nov; 24(24):6772-7. PubMed ID: 2866798
[TBL] [Abstract][Full Text] [Related]
7. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
Jadhav MA; Goldsberry WN; Zink SE; Lamb KN; Simmons KE; Riposo CM; Anokhin BA; Maurer MC
Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1246-1254. PubMed ID: 28687225
[TBL] [Abstract][Full Text] [Related]
8. Interactions of factor XIII with fibrin as substrate and cofactor.
Hornyak TJ; Shafer JA
Biochemistry; 1992 Jan; 31(2):423-9. PubMed ID: 1731900
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
[TBL] [Abstract][Full Text] [Related]
10. Probing interactions between the coagulants thrombin, Factor XIII, and fibrin(ogen).
Maurer MC; Trumbo TA; Isetti G; Turner BT
Arch Biochem Biophys; 2006 Jan; 445(1):36-45. PubMed ID: 16364233
[TBL] [Abstract][Full Text] [Related]
11. Factor XIIIa formation promoted by complexing of alpha-thrombin, fibrin, and plasma factor XIII.
Greenberg CS; Achyuthan KE; Fenton JW
Blood; 1987 Mar; 69(3):867-71. PubMed ID: 2880615
[TBL] [Abstract][Full Text] [Related]
12. The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin.
Siebenlist KR; DiOrio JP; Budzynski AZ; Mosesson MW
J Biol Chem; 1990 Oct; 265(30):18650-5. PubMed ID: 2211727
[TBL] [Abstract][Full Text] [Related]
13. The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen.
Naski MC; Fenton JW; Maraganore JM; Olson ST; Shafer JA
J Biol Chem; 1990 Aug; 265(23):13484-9. PubMed ID: 2380171
[TBL] [Abstract][Full Text] [Related]
14. The role of gamma A/gamma ' fibrinogen in plasma factor XIII activation.
Moaddel M; Falls LA; Farrell DH
J Biol Chem; 2000 Oct; 275(41):32135-40. PubMed ID: 10913112
[TBL] [Abstract][Full Text] [Related]
15. Roles of low specificity and cofactor interaction sites on thrombin during factor XIII activation. Competition for cofactor sites on thrombin determines its fate.
Philippou H; Rance J; Myles T; Hall SW; Ariens RA; Grant PJ; Leung L; Lane DA
J Biol Chem; 2003 Aug; 278(34):32020-6. PubMed ID: 12794066
[TBL] [Abstract][Full Text] [Related]
16. Thrombin activity is unaltered by N-terminal truncation of factor XIII activation peptides.
Isetti G; Maurer MC
Biochemistry; 2004 Apr; 43(14):4150-9. PubMed ID: 15065858
[TBL] [Abstract][Full Text] [Related]
17. Release of fibrinopeptides by the slow and fast forms of thrombin.
Vindigni A; Di Cera E
Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
[TBL] [Abstract][Full Text] [Related]
18. Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation.
Trumbo TA; Maurer MC
J Biol Chem; 2000 Jul; 275(27):20627-31. PubMed ID: 10801785
[TBL] [Abstract][Full Text] [Related]
19. The effect of fibrin polymers on thrombin-catalyzed plasma factor XIIIa formation.
Greenberg CS; Miraglia CC
Blood; 1985 Aug; 66(2):466-9. PubMed ID: 2861869
[TBL] [Abstract][Full Text] [Related]
20. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure.
Ariëns RA; Philippou H; Nagaswami C; Weisel JW; Lane DA; Grant PJ
Blood; 2000 Aug; 96(3):988-95. PubMed ID: 10910914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
